SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study (2022)

First Author: Xu M

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/dc22-0323

PubMed Identifier: 36161993

Publication URI: http://europepmc.org/abstract/MED/36161993

Type: Journal Article/Review

Parent Publication: Diabetes Care

Issue: 11

ISSN: 0149-5992